Schelling Chris 4
4 · Acer Therapeutics Inc. · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Schelling Chris
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2019-02-01+72,500→ 72,500 totalExercise: $24.46Exp: 2029-02-01→ Common Stock (72,500 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 1, 2020, and 1/16th of the shares vest each quarter thereafter for the remaining three years.